Gammagard Liquid

intravenous immunoglobulin (IVIG) 10% solution · Takeda

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Gammagard Liquid, covering 2015-12-03 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma [Phase 3]

See pricing